Woo Andrew H. 4
4 · Alzamend Neuro, Inc. · Filed Oct 18, 2021
Insider Transaction Report
Form 4
Woo Andrew H.
Director
Transactions
- Exercise/Conversion
Restricted Stock Grant
2021-10-15−47,222→ 50,000 totalExp: 2022-03-15→ Common Stock (47,222 underlying) - Exercise/Conversion
Common Stock
2021-10-15+47,222→ 50,000 total
Footnotes (3)
- [F1]Represents the vesting of restricted stock.
- [F2]Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
- [F3]The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022. 2,778 shares previously vested on September 13, 2021.